Clinical Outcomes of Upper-Extremity Deep Vein Thrombosis According to Cancer Status and Catheter Association: A RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) Registry Analysis
Journal of Thrombosis and Haemostasis · 2026-11 · 24 (11) · 4058-4069
DOI: 10.1016/j.jtha.2026.08.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-11. Verfasst von Philippe Debourdeau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive Care in Oncology, Hôpital Joseph Imbert, Arles, France. Electronic address: pdebourdeau@yahoo.fr. Hauptthemen laut MEDLINE: Neoplasms, Anticoagulants, Upper Extremity Deep Vein Thrombosis, Catheterization, Central Venous. Die Arbeit nennt 23 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
BACKGROUND: Upper-extremity deep vein thrombosis (UEDVT) is increasingly diagnosed because of the widespread use of venous catheters, particularly in patients with cancer. However, its clinical course and the optimal duration of anticoagulant therapy remain uncertain. METHODS: We analyzed 4979 patients with symptomatic isolated UEDVT enrolled in the Registro Informatizado de la Enfermedad TromboEmbólica, including 1383 patients with cancer and catheter-associated UEDVT, 599 with cancer and noncatheter-associated UEDVT, 921 without cancer and catheter-associated UEDVT, and 2076 without cancer and noncatheter-associated UEDVT. Outcomes included recurrent deep vein thrombosis, symptomatic pulmonary embolism, major bleeding, and all-cause mortality during anticoagulation and after treatment discontinuation. Competing-risk regression was used for thrombotic and bleeding outcomes, and Cox regression for mortality. RESULTS: Catheter-associated UEDVT was more frequent among patients with cancer than among those without cancer (70% vs 35%). Among patients with cancer, catheter-associated UEDVT was associated with lower all-cause mortality than noncatheter-associated UEDVT (22.6 vs 55.9 deaths per 100 patient-years; adjusted hazard ratio 0.39; 95% CI 0.31-0.49) and lower recurrent venous thromboembolism (VTE) rates (6.27 vs 9.60 per 100 patient-years). Among patients without cancer, catheter-associated UEDVT was associated with higher mortality (10.7 vs 4.32 deaths per 100 patient-years) and major bleeding (2.49 vs 0.61 per 100 patient-years), whereas recurrent VTE rates were similar irrespective of catheter status. Across all 4 groups, recurrent VTE remained infrequent after anticoagulation discontinuation. CONCLUSIONS: Clinical outcomes of UEDVT differ according to both cancer status and catheter association. The persistently low recurrence rates after anticoagulation discontinuation, particularly in catheter-associated UEDVT, support an individualized approach to anticoagulation duration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Supportive Care in Oncology, Hôpital Joseph Imbert, Arles, France. Electronic address: pdebourdeau@yahoo.fr.
- Department of Internal and Vascular Medicine, Nantes Université, CHU Nantes, Nantes, France; l'Institut du Thorax, Institut national de la santé et de la recherche médicale unité médicale de recherche1087/centre nationa…
- Department of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
- Department of Scientific Research Management, Hanoi Medical University and Hanoi Medical University Hospital, Hanoi, Vietnam.
- Department of Pneumonology, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
- Department of Pneumonology, Hospital General Universitario de Albacete, Albacete, Spain.
Zitieren
APA
Debourdeau, P., Espitia, O., Mazzolai, L., Bui, M. H., Gorostidi-Pérez, J., López-Miguel, P., Madridano, O., Bissacco, D., Soeiro, B., Monreal, M., & RIETE Investigators (2026). Clinical Outcomes of Upper-Extremity Deep Vein Thrombosis According to Cancer Status and Catheter Association: A RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) Registry Analysis. Journal of Thrombosis and Haemostasis, 24(11), 4058-4069. https://doi.org/10.1016/j.jtha.2026.08.032
Vancouver
Debourdeau P, Espitia O, Mazzolai L, Bui MH, Gorostidi-Pérez J, López-Miguel P, et al. Clinical Outcomes of Upper-Extremity Deep Vein Thrombosis According to Cancer Status and Catheter Association: A RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) Registry Analysis. Journal of Thrombosis and Haemostasis. 2026;24(11):4058-4069. doi:10.1016/j.jtha.2026.08.032
BibTeX
@article{Debourdeau2026,
author = {Debourdeau, Philippe and Espitia, Olivier and Mazzolai, Lucia and Bui, My Hanh and Gorostidi-Pérez, Juan and López-Miguel, Patricia and Madridano, Olga and Bissacco, Daniele and Soeiro, Bárbara and Monreal, Manuel and RIETE Investigators, RIETE Investigators},
title = {Clinical Outcomes of Upper-Extremity Deep Vein Thrombosis According to Cancer Status and Catheter Association: A RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) Registry Analysis},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {11},
pages = {4058--4069},
doi = {10.1016/j.jtha.2026.08.032}
}
EUVIMED